INSIGHTS ON DRUG DEVELOPMENT
-
Scale Your Viral Vector Production With A Streamlined Bioreactor System
Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge
The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Step-By-Step Guide To Tech Transfer Preparation And Execution
How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?
-
The History Of Chemical Nomenclature And ACD/Name6/18/2026
Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue5/6/2026
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Technology-Led Expansion Of Oligonucleotide Capabilities4/13/2026
Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.
-
Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists9/2/2025
Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.
-
Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit4/4/2025
Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.
DRUG DEVELOPMENT SOLUTIONS
-
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
Allow you students to gain practical hands-on experience exploring the following fundamentals of mass spectrometry:
-
Integrated drug discovery greatly benefits programs by blending various scientific disciplines into a unified team focused on your project.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.